title: Progestins initiate a luminal to myoepithelial switch in estrogen-dependent human breast tumors without altering growth.
abstract: Although long-term clinical use of progestins is associated with an increased incidence of breast cancers, their role in established cancers is unclear. Estrogens are considered to be the main mitogens in the majority of breast cancers. Whether progesterone affects proliferation and/or differentiation is under debate. To assess the role of progesterone in established breast cancers, we used T47D human breast cancer cells that are estrogen receptor (ER) positive and either progesterone receptor (PR) negative or positive for PRA, PRB, or both. These cells were grown as strictly estrogen-dependent solid tumors in ovariectomized female nude mice. Progesterone or medroxyprogesterone acetate (MPA) alone did not support tumor growth, nor did progesterone or MPA given simultaneously with estrogen significantly alter estrogen-dependent tumor growth. However, treatment of mice bearing ER+PR+ but not ER+PR- tumors with either progesterone or MPA increased expression of the myoepithelial cytokeratins (CK) 5 and 6 in a subpopulation of tumor cells. These CK5+/CK6+ cells had decreased expression of luminal epithelial CK8, CK18, and CK19. We conclude that progestins exert differentiative effects on tumors characterized by transition of a cell subpopulation from luminal to myoepithelial. This may not be beneficial, however, because such a phenotype is associated with poor prognosis.
authors.affiliation: Division of Endocrinology, Department of Medicine, University of Colorado Health Sciences Center, Aurora, Colorado 80045-7163, USA. Carol.Sartorius@uchsc.edu
authors.forename: Carol A
authors.initials: CA
authors.lastname: Sartorius
authors.forename: Djuana M E
authors.initials: DM
authors.lastname: Harvell
authors.forename: Tianjie
authors.initials: T
authors.lastname: Shen
authors.forename: Kathryn B
authors.initials: KB
authors.lastname: Horwitz
mesh_terms: D000818:Animals; D001943:Breast Neoplasms / Q000378:metabolism / Q000473:pathology*; D002454:Cell Differentiation / Q000187:drug effects / Q000502:physiology; D048708:Cell Growth Processes / Q000187:drug effects; D005260:Female; D006801:Humans; D007633:Keratins / Q000096:biosynthesis; D017258:Medroxyprogesterone Acetate / Q000097:blood / Q000494:pharmacology*; D051379:Mice; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D011374:Progesterone / Q000494:pharmacology*; D011960:Receptors, Estrogen / Q000096:biosynthesis; D011980:Receptors, Progesterone / Q000096:biosynthesis; D014183:Transplantation, Heterologous
chemical_list: D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D011374:Progesterone; D007633:Keratins; D017258:Medroxyprogesterone Acetate